Patents by Inventor Jingshan ZHANG

Jingshan ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240140975
    Abstract: The present invention relates to an antiviral application of nucleoside analogs. Specifically, the present invention relates to uses of nucleoside analogs and a pharmaceutical composition thereof as: (a) inhibitors for inhibiting the replication of coronaviruses, influenza viruses, respiratory syncytial viruses, flaviviridae viruses, filoviridae viruses and/or porcine epidemic diarrhea virus (PEDV); and/or (b) medicines for treating and/or preventing and mitigating diseases caused by coronavirus, influenza virus, respiratory syncytial virus, flaviviridae virus, filoviridae virus and/or porcine epidemic diarrhea virus (PEDV) infections. The nucleoside analogs according to the invention may treat and/or prevent and mitigate respiratory infection, pneumonia (COVID-19) and other related diseases caused by 2019 novel coronavirus infection.
    Type: Application
    Filed: November 27, 2023
    Publication date: May 2, 2024
    Inventors: Yuanchao XIE, Gengfu Xiao, Yang He, Leike Zhang, Haji Akber Aisa, Hualiang Jiang, Jingshan Shen
  • Patent number: 11919923
    Abstract: The present invention relates to an antiviral application of nucleoside analogs. Specifically, the present invention relates to uses of nucleoside analogs and a pharmaceutical composition thereof as: (a) inhibitors for inhibiting the replication of coronaviruses, influenza viruses, respiratory syncytial viruses, flaviviridae viruses, filoviridae viruses and/or porcine epidemic diarrhea virus (PEDV); and/or (b) medicines for treating and/or preventing and mitigating diseases caused by coronavirus, influenza virus, respiratory syncytial virus, flaviviridae virus, filoviridae virus and/or porcine epidemic diarrhea virus (PEDV) infections. The nucleoside analogs according to the invention may treat and/or prevent and mitigate respiratory infection, pneumonia (COVID-19) and other related diseases caused by 2019 novel coronavirus infection.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: March 5, 2024
    Assignees: Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Wuhan Institute of Virology, Chinese Academy of Science, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Vigonvita Life Sciences Co., Ltd.
    Inventors: Yuanchao Xie, Gengfu Xiao, Yang He, Leike Zhang, Haji Akber Aisa, Hualiang Jiang, Jingshan Shen
  • Patent number: 11876495
    Abstract: A working state adjustment method is applied to a terminal. A power amplifier (PA) is arranged on the terminal. The method includes: determining a target channel bandwidth in which the terminal works; determining a target working state in which the PA works among optional working states according to the target channel bandwidth, in which the optional working states correspond to at least two types of working modes respectively; and adjusting the PA to work in the target working state.
    Type: Grant
    Filed: March 24, 2022
    Date of Patent: January 16, 2024
    Assignee: Beijing Xiaomi Mobile Software Co., Ltd.
    Inventor: Jingshan Zhang
  • Publication number: 20230079103
    Abstract: A working state adjustment method is applied to a terminal. A power amplifier (PA) is arranged on the terminal. The method includes: determining a target channel bandwidth in which the terminal works; determining a target working state in which the PA works among optional working states according to the target channel bandwidth, in which the optional working states correspond to at least two types of working modes respectively; and adjusting the PA to work in the target working state.
    Type: Application
    Filed: March 24, 2022
    Publication date: March 16, 2023
    Applicant: Beijing Xiaomi Mobile Software Co., Ltd.
    Inventor: Jingshan ZHANG